Sean E McGuire, MD, PhD
Affiliations: | 2009- | Mol and Cell Biology/Radiation Oncology | Baylor College of Medicine/MD Anderson |
Area:
Radiation Oncology; Prostate cancer; Cancer cell metabolism; metabolic imagingWebsite:
https://faculty.mdanderson.org/profiles/sean_mcguire.htmlGoogle:
"Sean McGuire"Mean distance: (not calculated yet)
Cross-listing: MPROTree - Cell Biology Tree
Children
Sign in to add traineeDavid Allen Bader | grad student | 2019 | Baylor College of Medicine (Cell Biology Tree) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Nikitas J, Ong WL, Carrier N, et al. (2023) Prostate-Specific Antigen Response to Androgen Deprivation Therapy in the Neoadjuvant Setting for High-risk Prostate Adenocarcinoma (PIRANHA): Pooled Analysis of Two Randomized Clinical Trials. International Journal of Radiation Oncology, Biology, Physics |
Vantaku V, Putluri V, Bader DA, et al. (2020) Correction: Epigenetic loss of AOX1 expression via EZH2 leads to metabolic deregulations and promotes bladder cancer progression. Oncogene |
Boyce-Fappiano D, Bathala TK, Ye R, et al. (2020) Predictors of urinary toxicity with MRI-assisted radiosurgery for low-dose-rate prostate brachytherapy. Brachytherapy |
Abu-Gheida I, Bathala TK, Maldonado JA, et al. (2020) Increased frequency of Mesorectal and Perirectal LN involvement in T4 Prostate Cancers. International Journal of Radiation Oncology, Biology, Physics |
Bagley AF, Anscher MS, Choi S, et al. (2020) Association of Sociodemographic and Health-Related Factors With Receipt of Nondefinitive Therapy Among Younger Men With High-Risk Prostate Cancer. Jama Network Open. 3: e201255 |
Bader DA, McGuire SE. (2020) Tumour metabolism and its unique properties in prostate adenocarcinoma. Nature Reviews. Urology |
Lin C, Salzillo TC, Bader DA, et al. (2019) Prostate Cancer Energetics and Biosynthesis. Advances in Experimental Medicine and Biology. 1210: 185-237 |
Tang C, Hoffman KE, Allen PK, et al. (2019) Contemporary prostate cancer treatment choices in multidisciplinary clinics referenced to national trends. Cancer |
Vantaku V, Putluri V, Bader DA, et al. (2019) Epigenetic loss of AOX1 expression via EZH2 leads to metabolic deregulations and promotes bladder cancer progression. Oncogene |
Bader DA, Hartig SM, Putluri V, et al. (2019) Mitochondrial pyruvate import is a metabolic vulnerability in androgen receptor-driven prostate cancer. Nature Metabolism. 1: 70-85 |